← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

A

$ Value

$0

Shares

53,300

Price

$0

Filed

Feb 20

Insider

Name

Levy Adam Scott

Title

CFO and Secretary

CIK

0001693134

Roles

Officer

Transaction Details

Transaction Date

2026-02-19

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

53,300

Footnotes

Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant. | The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant

Filing Info

Accession No.

0001933414-26-000037

Form Type

4

Issuer CIK

0001933414

Levy Adam Scott's History

Date Ticker Type Value
2026-02-19 MLYS A $0
2026-02-19 MLYS A $0
2026-01-12 MLYS $346K
2025-11-11 MLYS M $210K
2025-11-11 MLYS M $551K
2025-11-11 MLYS M $628K
2025-11-11 MLYS M $102K
2025-11-11 MLYS $43K
2025-11-11 MLYS $473K
2025-11-11 MLYS $67K

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
AKKARAJU SRINIVAS 2026-02-19
SBLENDORIO GLENN 2026-02-19
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$1.9M 2026-04-17
Levy Adam Scott
CFO and Secretary
2026-02-19
DiRocco Derek 2026-02-19
Karydas Daphne $75K 2026-03-31
Slingsby Brian Taylor 2026-02-19
Gold Alexander M 2026-02-19